Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

bendamustine

bendamustine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Treanda SOLUTION, INTRAVENOUS 90 mg/mL      
Bendeka SOLUTION, INTRAVENOUS 100 mg/4 mL      
Vivimusta SOLUTION, INTRAVENOUS 100 mg/4 mL      
VIEW MORE Antineoplastic Agents
CLASS
100000
Comments:

Treanda/Bendeka/Vivimusta are classified as formulary, restricted to oncology. Due to high cost, deferral to the outpatient setting should be explored. If ordered, contact a member of pharmacy administration.

Treanda, Bendeka, and Vivimusta are classified as therapeutically equivalent and interchangeable. The most cost-effective agent will be utilized.

Reviewed: July 29, 2008 & 22 March 2016 (Bendeka), February 2025 (Vivimusta)

 

Bendamustine (Vivimusta) Spotlight

Last updated: Mar. 21, 2025






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved